New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
05:36 EDTPANW, JNPRPalo Alto upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded Palo Alto Networks (PANW) citing an attractive risk/reward due to concerns around the Juniper (JNPR) litigation. Wells sees reasonable downside risk from the litigation and raised its price target for shares to $75-$81 from $53-$56.
News For PANW;JNPR From The Last 14 Days
Check below for free stories on PANW;JNPR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
07:55 EDTPANWPalo Alto business appears to be beating expectations, says Oppenheimer
Oppenheimer reports that its checks indicate that Palo Alto's business is tracking ahead of consensus estimates this quarter. The firm raised its price target on the shares to $90 from $80 and keeps an Outperform rating on the stock.
August 31, 2014
13:27 EDTJNPR, PANWAT&T to hold a conference
16th Annual AT&T Cyber Security Conference will be held in New York on September 3-4 with webcast availability on September 4 at 9 am; Webcast Link
13:20 EDTJNPRCitigroup to hold a conference
Global Technology Conference to be held in New York on September 2-4.
August 28, 2014
06:54 EDTPANWPalo Alto coverage resumed with a Buy at Stifel
Subscribe for More Information
August 20, 2014
08:02 EDTPANWPalo Alto expands global distribution agreement with Westcon Group
Subscribe for More Information
August 19, 2014
11:05 EDTJNPRImperva seen as takeover candidate under new CEO
Subscribe for More Information
08:42 EDTJNPRImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use